Clindamycin

Medical Purchasing Solutions, LLC🇺🇸 United States

FDA Page

Effective Date: Jan 24, 2020
Approval ID: 6937488f-b336-b6bf-e053-2a91aa0a2ea3
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

To reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin and other antibacterial drugs, clindamycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Clindamycin Injection USP is for Intramuscular and Intravenous Use.

Quick Stats

Total Products1

Labelers2

Label Sections15

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.